To the full analysis
Buyback calculator for Intellia Therapeutics
Intellia Therapeutics stock: key metrics
NTLAIntellia Therapeutics had an operating margin of −651.7% and a return on invested capital (ROIC) of −87.6% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2014 | no data | no data | no data |
| 2015 | −84.8% | −221.9% | −205.1% |
| 2016 | −93.2% | −195.2% | −192.0% |
| 2017 | −159.0% | −266.3% | −258.6% |
| 2018 | −192.8% | −298.6% | −280.4% |
| 2019 | −151.5% | −246.8% | −230.9% |
| 2020 | −159.4% | −235.5% | −231.5% |
| 2021 | 79.2% | −810.4% | −810.5% |
| 2022 | 85.5% | −879.0% | −909.8% |
| 2023 | 75.3% | −1,420.5% | −1,326.5% |
| 2024 | 82.2% | −923.1% | −896.8% |
| 2025 | 76.5% | −651.7% | −609.9% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2014 | −100.0% | −49.5% | −100.0% |
| 2015 | −18.4% | −26.6% | −15.1% |
| 2016 | −15.1% | −15.0% | −10.6% |
| 2017 | −22.5% | −17.9% | −18.0% |
| 2018 | −30.7% | −22.0% | −24.6% |
| 2019 | −36.9% | −27.8% | −29.8% |
| 2020 | −25.5% | −23.7% | −19.8% |
| 2021 | −25.8% | −23.8% | −20.7% |
| 2022 | −38.4% | −28.3% | −31.2% |
| 2023 | −45.8% | −31.6% | −37.0% |
| 2024 | −59.5% | −37.3% | −43.6% |
| 2025 | −61.5% | −87.6% | −49.0% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 31 May 2017)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.